Report finds $529M overpayment for anemia drugs in 2011

05/13/2013 | Fox Business

An Office of Inspector General report found that Medicare overpaid by $529 million for anemia drugs given to dialysis patients in 2011. Had U.S. government spending been based on current drug usage levels, which have fallen since 2007, the government would have saved $510 million. A decline in the use of iron deficiency drugs led to an overpayment of $19 million, the report said. CMS is expected to release a proposal this summer to change next year's reimbursement rate.

View Full Article in:

Fox Business

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC